BCD020a: A Study of the Efficacy and Safety of Rituximab bio similar study in Subjects With CD20-positive indolent non-Hodgkin lymphoma |
|
|
| Completed | 3 | 92 | India, Russian Federation, Ukraine | BCD-020 (rituximab biosimilar) | Biocad | NHL | | | | |
NCT05078177: Safety and Efficacy of Intrathecal Rituximab in Patients With Multiple Sclerosis |
|
|
| Recruiting | 1 | 40 | RoW | Rituximab, Mabthera, Reditux, Acellbia | St. Petersburg State Pavlov Medical University | Multiple Sclerosis | 12/22 | 12/24 | | |